GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kontafarma China Holdings 1312.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.03

—

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2025

Revenue

HK$914.7m

FY2016FY2025

Net income

−HK$427.8m

FY2016FY2025

Free cash flow

HK$53.2m

FY2016FY2025

Shareholders' equity

HK$553.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueHK$914.7mHK$897.5mHK$809.1mHK$894.1mHK$961.1mHK$1.01bnHK$921.1mHK$2.09bnHK$1.34bnHK$633.3m
Research and developmentHK$8.4mHK$34.6mHK$20.8mHK$29.1mHK$45.6mHK$36.5mHK$33.7mHK$25.3mHK$23.7mHK$4.5m
Operating income−HK$242.8m−HK$90.4m−HK$32.2m−HK$137.3mHK$33.8mHK$32.3mHK$133.6mHK$89.9mHK$26.3m−HK$41.3m
Net income−HK$427.8m−HK$75.5m−HK$28.8m−HK$41.5m−HK$15.0m−HK$267.2mHK$36.1mHK$32.5m−HK$1.8m−HK$37.1m
Diluted earnings per share-0.08-0.01-0.01-0.01-0.00-0.050.010.01-0.00-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsHK$1.07bnHK$1.59bnHK$1.73bnHK$2.12bnHK$2.56bnHK$2.54bnHK$4.00bnHK$3.34bnHK$3.44bnHK$3.15bn
Cash and short-term investmentsHK$66.1mHK$90.6mHK$87.7mHK$142.6mHK$184.0mHK$194.8mHK$236.4mHK$260.2mHK$496.2mHK$701.6m
Total liabilitiesHK$588.9mHK$625.9mHK$665.4mHK$964.2mHK$1.22bnHK$1.19bnHK$2.08bnHK$1.43bnHK$1.60bnHK$1.51bn
DebtHK$203.7mHK$297.2mHK$333.8mHK$590.7mHK$729.0mHK$634.3mHK$898.0mHK$549.4mHK$806.9mHK$1.08bn
Shareholders' equityHK$553.3mHK$978.7mHK$1.06bnHK$1.10bnHK$1.19bnHK$1.21bnHK$1.41bnHK$1.39bnHK$1.22bnHK$1.13bn
Shares outstanding5,579m5,579m5,579m5,579m5,579m5,579m5,579m5,579m5,455m4,949m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsHK$76.7mHK$47.0mHK$37.1m−HK$2.2mHK$75.1mHK$206.9mHK$25.7mHK$66.9m−HK$47.3mHK$12.4m
Capital spending−HK$23.5m−HK$13.6m−HK$24.2m−HK$51.7m−HK$124.4m−HK$155.9m−HK$90.2m−HK$85.7m−HK$91.4m−HK$50.0m
Free cash flowHK$53.2mHK$33.4mHK$12.9m−HK$53.8m−HK$49.3mHK$51.0m−HK$64.6m−HK$18.8m−HK$138.6m−HK$37.6m
Dividends paid————————−HK$3.5m−HK$860,000

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Sept 2023Jun 2023
RevenueHK$383.3mHK$462.0mHK$452.7mHK$439.0mHK$458.5mHK$378.4mHK$189.2mHK$430.7m
Operating income−HK$23.4m−HK$47.1m−HK$195.8m−HK$74.7mHK$9.6m−HK$90.1m−HK$27.2m−HK$74.2m
Net income−HK$67.4m−HK$145.4m−HK$282.5m−HK$80.3mHK$4.7m−HK$68.0m−HK$34.0mHK$39.1m
Diluted earnings per share-0.01-0.03-0.05-0.010.00-0.01-0.010.01
Cash from operationsHK$11.0mHK$18.0mHK$48.0m−HK$3.0mHK$45.0mHK$29.0mHK$14.0m−HK$1.0m
Capital spending−HK$9.0m−HK$10.0m−HK$13.0m−HK$4.0m−HK$9.0m−HK$6.0m−HK$3.0m−HK$17.0m
Free cash flowHK$2.0mHK$8.0mHK$35.0m−HK$7.0mHK$36.0mHK$23.0mHK$11.0m−HK$18.0m
Total assetsHK$997.4mHK$1.07bnHK$1.15bnHK$1.59bnHK$1.69bnHK$1.73bnHK$1.73bnHK$1.83bn
Cash and short-term investmentsHK$67.6mHK$66.1mHK$78.3mHK$90.6mHK$78.7mHK$87.7mHK$87.7mHK$170.6m
DebtHK$128.6mHK$203.7mHK$287.3mHK$297.2mHK$347.0mHK$333.8mHK$39.5mHK$378.8m
Shareholders' equityHK$510.2mHK$553.3mHK$685.0mHK$978.7mHK$1.06bnHK$1.06bnHK$1.06bnHK$1.12bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.8%-1.9%7.0%
Operating income20.9%—15.2%
Net income117.6%9.9%28.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-18.4%-14.3%-8.0%-2.6%
Net margin-27.8%-16.3%-15.6%-7.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-0.4-1.9-7.0-6.0-18.2-1.824.742.6-1540.5-90.8
Price to sales0.20.20.30.30.30.51.00.72.15.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 May 2013.

FY2013FY2012
Paid in the year0.0040.004
  • 5-for-1 split · 20 Jan 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.